:::

詳目顯示

回上一頁
題名:皮膚砷癌之流行病學特徵與危險因子
書刊名:中華公共衛生雜誌
作者:薛玉梅陳建仁
作者(外文):Hsueh, Yu-meiChen, Chien-jen
出版日期:1996
卷期:15:1
頁次:頁1-26
主題關鍵詞:皮膚砷癌流行病學危險因子Arsenic-induced skin cancerEpidemiologyRisk factor
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:42
     本文係綜論皮膚砷癌的流行病學特徵與危險因子。砷引起的皮膚癌屬於非黑色素 瘤皮膚癌。一般的非黑色素瘤皮膚癌常見於白種人,男性比女性有較高的發生率。它好發於 臉、頭及頸部,軀幹及上肢是次常發部位;而且隨日曬程度增加。紫外線輻射、化學物質、 游離輻射線、免疫因素、宿主因素為其主要之危險因子。砷是一種類金屬,往往經由礦脈、 銅精煉廠、工業和農業用途,造成環境的污染。引起健康危害的砷主要是無機砷,它會引起 胃腸道障礙、心臟血管疾病、神經病變、肝腎障礙、皮膚病變和癌症。砷已被公認為人類之 皮膚和肺的致癌物。砷引起皮膚的主要暴露途徑為藥物,環境和職業暴露。皮膚砷癌的發生 部位大多為非日曬部位,即手掌、腳蹠、肢端和軀幹,且屬全身多發生的表皮癌化病變。臺 灣西南沿海烏腳病盛行地區的皮膚癌盛行率及死亡率,與深井水含砷濃度呈劑量效應關係。 吾人研究發現烏腳病高盛行地區的皮膚盛行率,與慢性砷暴露指標,包括烏腳病盛行地區居 住年數、飲用深井水年數、飲用水平均砷濃度、和累積砷暴露等,均呈現顯著的劑量效應關 係。皮膚砷癌盛行率也與從事鹽田工作、B 型肝炎帶原且肝功能不良、食用蕃薯簽年數偏高 有顯著相關。人體內的無機砷代謝能力,尿液砷物種分佈,血清微量營養素濃度,以及免疫 能力與皮膚癌的相關性,尚待進一步証實。皮慮病變可作為無機砷長期暴露的生物指標,過 去在烏腳病盛行地區的研究指出,皮膚癌和內臟癌的標準死亡比與累積死亡率,都比臺灣地 區一般人口顯著偏高。砷引起皮膚癌的機轉,以及皮膚癌與內臟癌之間的關係,均是值得探 討的主題。
     Research on the epidemiologic characteristics and risk factors of arsenic-induced skin cancer were reviewed in detail. Arsenic-induced skin cancers are nonmelanoma skin cancers. Nonmelanoma skin cancers are much more common in white than in black or other dark- skinned populations. The incidence of nonmelanoma skin cancer is greater in males than in females. It occurs mostly on the face, head and neck, while the trunk and upper extremities are the next most common sites. The risk of nonmelanoma skin cancer is asscciated with the sunlight exposure in a dose-response relationship. Ultraviolet radiation, chemicals, ionizing radiation, immunologic and other host factors are risk factors for nonmelanoma skin cancer. Arsenic is a metalloid element, contaminating the environment through leaching from mineral ores, copper smelting, and other industrial and agricultural sources. Inorganic arsenic is much more toxic than organic arsenic compounds. It induces gastrointestinal disturbance, cardiovascular diseases, neurological disorders, liver and kidney damage, skin lesions and cancers. Inorganic arsenic has been documented as a human carcinogen of the skin and lung. Exposure to inorganic arsenic from medicinal, environmental and occupational sources has been found to be associated with the development of skin cancer. In contrast with nonmelanoma cancers of other etiologies, arsenic-induced skin cancers occur on every part of the body, especailly marked in areas unexposed to sunlight, such as the palms, soles, extremities and trunk. They are multifocal and randomly distributed epidermal carcinoma lesions. A dose-response relationship between the prevalence and mortality of skin cancer and the arsenic concentration of artesian well water has been well documented in a black- foot disease endemic area on the southwest coast of Taiwan. A significant dose-response relation has recently been reported between skin cancer prevalence and chronic arsenic exposure, indexed by duration of living in the endemic area, duration of consuming high-ar- senic contaminated artesian well water, average arsenic in artesian well water and cumulative arsenic exposure. Salt field working, chronic HBsAg carrier status with liver dysfunction, and high consumption of dried sweet potatoes have been found to be significantly associated with an increased prevalence of arsenic-induced skin cancer in those living in the blackfoot disease endemic area. Arsenic metabolism capacity, distribution of urinary arsenic species, serum level of micronutrients and immunologic profiles need to be explored for their associations with arsenic-induced skin cancer. Skin cancer has been considered as a biological marker for chronic inorganic arsenic exposure. Both standardized mortality ratio and cumulative mortality of skin cancer and various internal cancers have been reported to be significanlty higher among residents in the blackfoot disease endemic area than in the general population in Taiwan. The mechanism of arsenic-induced skin cancer as well as the association between skin cancer and internal cancrs deserve further investigation.
期刊論文
1.Tseng, W. P.(1977)。Effects and dose-response relationships of skin cancer and black foot disease with arsenic。Environ Health Perspect,19,109-119。  new window
2.Wu, M. M.、Kuo, T. L.、Hwang, Y. H.、Chen, C. J.(1989)。Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases。Am J Epidemiol,130(6),1123-1132。  new window
3.Chen, Chung-Jen、Chen, Chao W.、Wu, M.-M.、Kuo, T. L.(1992)。Cancer Potential in Liver, Lung, Bladder and Kidney Due to Ingested Inorganic Arsenic in Drinking Water。British Journal of Cancer,66(5),888-892。  new window
4.Chen, C. J.、Wu, M. M.、Lee, S. S.、Wang, J. D.、Cheng, S. H.、Wu, H. Y.(1988)。Atherogenicity and carcinogenicity of high-arsenic artesian well water: multiple risk factors and related malignant neoplasms of blackfoot disease。Arteriosclerosis,8(5),452-460。  new window
5.Chen, C. J.、Kuo, T. L.、WU, M. M.(1988)。Arsenic and cancers。Lancet,1,141-145。  new window
6.Uroach, F.(1971)。Geographic Distribution of Skin Cancer。Journal of surgical oncology,3,219-234。  new window
7.Silverberg, E.、Squires, T. S.、Boring, C. C.(1990)。Cancer Statistics。CA: a cancer journal for clinicians,40(1),9-26。  new window
8.Glass, A. G.、Hoover, R. N.(1989)。The emerging epidemic of melanoma and squamous cell skin cancer。Journal of the American Medical Association,262,2097-2100。  new window
9.Roberts, D. L.(1990)。Incidence of non-melanoma skin cancer in West Glamorgan, South Wales。The British journal of dermatology,122,399-403。  new window
10.Green, Adele、Battistutta, Diana(1990)。Incidence and determinants of skin cancer in a high-risk Australian Population。Int J Cancer,46,356-361。  new window
11.Stoll, H. L.、Schwartz, R. A.(1992)。Squamous cell carcinoma。Dermatology in general medicine,746-758。  new window
12.Sterlind, A.、Hou-Jensen, K. O.、Muller, Jensen(1988)。Incidence of cutaneous malignant melanoma in Denmark 1978-1982. Anatomic site distribution, histologic types, and comparison with non-melanoma skin cancer。British journal of cancer,58,385-391。  new window
13.(1991)。National Institutes of Health Consensus Development Conference Statement: Sunlight, ultraviolet radiation and the skin。J Am Acad Dermatol,24(4),608-612。  new window
14.Stern, R. S.、Weinstock, M. C.、Baker, S. G.(1986)。Risk reduction for nonmelanoma skin cancer with childhood sunscreen use。Archives of dermatology,122,537-545。  new window
15.Kripke, M. L.(1974)。Antigenicity of murine skin turners induced by UV。light J Natl Cancer Inst,53,1333-1336。  new window
16.Stern, R. S.、Thfbodean, L. A.、Koeinerman, R. A.(1979)。Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis。The New England journal of medicine,300,809-813。  new window
17.Kripke, M. L.(1988)。Immunoregulation of Carcinogenesis: Past, Present, and Future。J Natl Cancer Inst,80,722-727。  new window
18.Lee, M. M.、Wick, M. W.(1990)。Bowen's Disease。CA (a ancer J for clinic),40,237-242。  new window
19.Neubauer, O.(1947)。Arsenical cancer: a review。Br J Cancer,1,192-251。  new window
20.Andreae, M. O.(1978)。Distribution and speciation of arsenic in natural waters and some marine algal。Deep Sea Res,25,391-402。  new window
21.Welch, K.、Higgins, I.、Oh, M.、Burchfiel, C.(1982)。Arsenic exposure, smoking, and respiratory cancer in copper workers。Archives of Environmental Health: An International Journal,37,325-335。  new window
22.Yeh, S.、How, S. W.、Lin, C. S.(1968)。Arsenic cancer of skin。Cancer,21,312-39。  new window
23.Yeh, S.(1973)。Skin cancer in chronic arsenicism。Human Pathol,4,469-485。  new window
24.Cebrián, M. E.、Albores, k.、Aguilar, M.、Blakely, E.(1983)。Chronic arsenic poisoning in the north of Mexico。Human Toxicol,2(1),121-133。  new window
25.Blackwell, R. Q.、Yang, T. H.、Ai, I.(1961)。Preliminary report on arsenic levels in water and food from the endemic blackfoot area。J Formosan Med Assoc,60,1139-1140。  new window
26.Yeh, S.(1963)。Studies on endemic chronic arsenical poisoning in southwest coast of Taiwan。Reports, Institute of pathology, National Taiwan University,14,1-23。  new window
27.Brownstein, M.、Rabinowitz, A. D.(1979)。The precursors of cutaneous squamous cell carcinoma。Int J Dermatol,18,1-16。  new window
28.Feinglass, E. J.(1973)。Arsenic intoxication from well water in the United States。N Engl J Med,288,828-830。  new window
29.Nelson, W. C.、Lykins, M. H.、Mackey, J.、Newill, V. A.、Finklea, J. F.、Hammer, D. L.(1973)。Mortality among orchard workers exposed to lead arsenate spray: a cohort study。J Chron Dis,26,105-118。  new window
30.Marafante, E.、Rade, J.、Sabbioni, E.(1981)。Intracellular interaction and metabolic fate of arsenite in the rabbit。Clin Toxicol,18(11),1335-1341。  new window
31.Vahter, M.、Norin, H. L.(1980)。Metabolism of 74 As-labelled trivalent and pentavalent inorganic arsenic in mice。Environ Res,21,446-457。  new window
32.Buchet, J. P.、Lauwerys, R.、Roels, H.(1981)。Urinary excretion of inorganic arsenic and Its metabolites after repeated ingestion of sodium metaarscnite by volunteers。Int Arch Occup Environ Health,48,111-118。  new window
33.Pinto, S. S.、McGill, C. M.(1953)。Arsenic trioxide exposure in industry。Ind Med Surg,22,281-287。  new window
34.Holland, R. H.、Wilson, R. H.、Acevedo, A. R.、McCall, M. S.、Clark, D. A.、Lanz, H. C.(1959)。The cigarette smoke-arsenic-cancer of the lung problem。Acta Unio Int Contra Cancrum,15,608-611。  new window
35.Grab, L. G.、Hine, C. H.(1977)。Arsenical neuropathy: residual effects following acute industrial exposure。J Occup Med,19(8),567-568。  new window
36.Charbonneau, S. M.、Spencer, K.、Bryce, F.、Sandi, E.(1978)。Arsenic excretion by monkeys dosed with arsenic containing fish or with inorganic arsenic。Bull Environ Contam Toxicol,20,470-407。  new window
37.Bertolero, F.、Marafante, E.、Edel, Rade J.、Pietro, R.、Sabbioni, E.(1981)。Biotransfo-rmation and intracellular binding of arsenic in tissues of rabbits after intraperitoneal administration of As-74 labelled arsenite。Toxicology,20,35-44。  new window
38.Mitchell, R. A.、Chang, B. F.、Huang, C. H.、Demaster, E. G.(1971)。Inhibition of mitochondrial energy--linked functions by arsenate. Evidence for a nonhydrolytic mode of inhibitor action。Biochemistry,10(11),2049-2054。  new window
39.Lindgren, A.、Vahter, M.、Dencker, L.(1982)。Autoradiographic studies on the distribution of arsenic in mice and hamsters administered 74 As-arsenite or 74 As-arsenate。Acta Pharmacol Toxicol,51,253-265。  new window
40.McBride, B. G.、Merilees, H.、Cullen, W. R.、Pickett, W.(1978)。Organometals and Organometalloids。Acs Symposium Series 82, American Chemical Society,94-115。  new window
41.Tam, K. H.、Charbonneau, S. M.、Bryce, F.、Lacroix, G.(1978)。Separation of arsenic metabolites in dog plasma and urine following intravenous Injection of 74 As。Anal Biochem,86,505-511。  new window
42.Charbonneau, S. M.、Hollins, J. G.、Tam, G. K.、Bryce, F.、Ridgeway, J. M.、Willes, R. F.(1980)。Whole body retention, excretion, and metabolism of 75 As-arsenic acid in the hamster。Toxicol Lett,5,175-182。  new window
43.Inamasu, T.(1983)。Arsenic metabolites in rsenic metabolites in urine and feces of hamsters pretreated with PCB。Toxicol Appl Pharmacol,71,142-152。  new window
44.Crecelius, E. A.(1977)。Changes in the chemical speciation of arsenic following ingestion by man。Environ Health Perspect,19,147-150。  new window
45.Smith, T. J.、Crecelius, E. A.、Reading, J. C.(1977)。Airborne arsenic exposure and excretion of methylated arsenic compounds。Environ Health Perspect,19,89-93。  new window
46.Yamauchi, H. F.、Yamamura, Y.(1979)。Dynamic change of urinary arsenic and methyla-rsenic compounds in human urine after oral intake as arsenic trioxide。Ind Health,17,79-83。  new window
47.Mealey, J. R.、Brownell, G. L.、Sweet, W. H.(1959)。Radioarsenic in plasma, urine, normal tissue, and intracranial neoplasm。Arch Neurol Psychiatr,81,310-320。  new window
48.Pommy, C.、Charbonneau, S. M.、McCullough, R. S.、Tam, G. K.(1980)。Human retention studies with 74As。Toxicol Appl Pharmacol,53(3),550-556。  new window
49.Vallee, B. L.、Ulmer, D. D.、Wacker, W. E.(1960)。Arsenic toxicology and biochemistry。Arch Ind Health,21,132-151。  new window
50.Hindmarsh, J. J.、McCurdy, R. F.(1986)。Clinical and environmental aspects of arsenic toxicity。CRC Crit Rev Clin Lab Sci,23,315-347。  new window
51.Armstrong, C. W.、Stroube, R. B.、Rubio, T.(1984)。Outbreak of fatal arsenic poisoning caused by contaminated drinking water。Arch Environm Health,39,276-279。  new window
52.Hamamoto, E.(1955)。Infant arsenic poisoning by powdered milk。Jap Med J,1649,2-12。  new window
53.Zaldivar, R.(1974)。Arsenic contaminated of drinking water and foodstuffs causing endemic chronic poisoning。Beitr Path,151,384-400。  new window
54.Mizuta, N.、Mizuta, M.(1956)。An outbreak of acute arsenic poisoning caused by arsenic-contaminated soy sauce (shoye)。Buft Yamaguchi Med Sch,4,131-50。  new window
55.Rosenberg, H. G.(1974)。Systemic arterial disease and chronic arsenicism in infants。Arch Pathol,97,360-365。  new window
56.Salcedo, J. C.、Portales, A.、Landecho, E.、Diaz, R.(1984)。Transverse study of a group of patients with vasculopathy from chronic arsenic poisoning in Communities of the Francisco de Madero and San Pedro Districts, Coahuila Mexico。Revista de la Facultad de Medicna de Torreon,12,12-16。  new window
57.Beckett, W. S.、Moore, J. L.、Keogh, J. P.、Bleecker, M. L.(1986)。Acute encephalopathy due to occupational exposure to arsenic。Br J Ind Med,43,66- 67。  new window
58.Danan, M.、Dally, S.、Conso, F.(1984)。Arsenic-induced encephalopathy (letter to the editor)。Neurology,34,1524。  new window
59.Franklin, M.、Bean, W.、Harden, R. C.(1950)。Fowler's solution as an etiologic agent in cirrhosis。Am J Med Sci,219,589-596。  new window
60.Huang, Y. Z.、Qian, X. C.、Wang, G. Q.(1985)。Chronic arsenism fn Xinjiang。Chinese Med J,98,219-222。  new window
61.Granstein, R. D.、Sober, A. J.(1981)。Drug and heavy metal induced hyperpigmentation。J Am Acad Dermatol,5,1-18。  new window
62.Sommers, S. C.、McMarnus, R. G.(1953)。Multiple arsenical cancers of skin and internal organs。Cancer,6,347-359。  new window
63.Borgono, J. M.、Vincent, P.、Venturino, H.、Infante, A.(1977)。Arsenic in the drinking water of the city of Antofagasta epidemiological and clinical study before and after installation of a treatment plant。Eviron Health Perspect,19,103-105。  new window
64.Biagint, R. E.、Quiroga, G. C.、Elias, V.(1974)。Chronic hydroarsenism in ururau。Archivos Agentinos de Dematologia,24(1),8-11。  new window
65.Yoshikawa, T.、Utsumi, J.、Okada, T.、Moriuchi, M.、Ozawa, K.、Kaneko, Y.(1960)。Concerning the mass outbreak of chronic arsenic toxicosis in Niigata Prefecture。Chiryo,42,1739-1749。  new window
66.Fierz, U.(1965)。Catamnestic research into the side effects of inorganic arsenotherapy in skin disease。Dermatologica,131,41-58。  new window
67.Watrous, R. M.、McCaughey, M. B.(1945)。Occupational exposure to arsenic: In the manufacture of arsphenamine and related compounds。Ind Med,14,639-646。  new window
68.Hamada, T.、Horiguchi, S.(1976)。Occupational chronic arsenical poisoning. On the cutaneous manifestations。Jpn J Ind Health,117,160-164。  new window
69.Perry, K.、Bowler, R. G.、Buckell, H. M.、Druett, H. A.、Schilling, R. S.(1948)。Studies in the incidence of cancer in a factory handling inorganic compounds of arsenic II: Clinical and environmental investigation。Br J Ind Med,5,6-15。  new window
70.Huchison, J.(1988)。On some examples of arsenic-kera-tosis of the skin and of arsenic-cancer。Pathol Soc Lond 1888,39,352-363。  new window
71.Hill, A. B.、Fanning, E. l.(1948)。Studies on the incidence of cancer in a factory handling in organic compounds of arsenic. I. Mortality experience in the factory。Br J Ind Med,5,1-6。  new window
72.Luchtrath, H.(1960)。The consequences of chronic arsenic poisoning among moselle wine growers: pathonatomica丨 investigations of post-morten examinations performed between 1960 and 1977。J Cancer Res Clin Oncol,105,173-182。  new window
73.Roth, F.(1958)。The sequelae of chronic arsenic Poisoning in Moselle Vintner。DIR Med Mon,2,172-175。  new window
74.Ott, M. G.、Holder, B. B.、Gordon, H. I.(1974)。Respiratory cancer and occupational exposure to arsenicals。Arch Environ Helth,29,250-255。  new window
75.Mabuchi, K.、Lilienfeld, A.、Snell, L.(1979)。Lung caner among pesticide workers exposed to inorganic arsenicals。Arch Environ Health,34,312-320。  new window
76.Lee, A. M.、Fraumeni, J. F. Jr.(1969)。Arsenic and respiratory cancer in man: An occupational study。J Natl Cancer Inst,42,1045-1052。  new window
77.Milham, S. Jr.、Strong, T.(1974)。Huan arsenic exposure in relation to a copper smelter。Environ Res,7,176-182。  new window
78.Tokudome, S.、Kuratsume, M.(1976)。A cohort study on mortality from cancer and other causes among workers at a metal refinery。Int J Cancer,17(3),310-317。  new window
79.Brown, C. C.、Chu, K. C.(1983)。Implication of the multistage the ory of cacinogenesis applied to occupational arsenic exposure。J Natl Cancer Inst,70,455-463。  new window
80.Enterline, P. E.、Henderson, V. L.、Marsh, G. M.(1987)。Exposure to arsenic and respiratory cancer。Am J Epidemiol,125(6),929-938。  new window
81.Lubin, J. H.、Pottern, L. M.、Blot, W. J.、Tokudome, S.、Stone, B. J.、Fraumeni, J. R. Jr.(1981)。Respriratory cancer among copper smelter workers: recent mortality statistics。J Occup Med,23,779-784。  new window
82.Lee, F. A.(1986)。Cumulative exposure to arsenic and its relationship to respiratory cancer among copper smelter employees。J Occup Med,28(4),296-302。  new window
83.Pinto, S. S.、Enterline, P. E.、Henderson, V.、Varner, M. O.(1977)。Mortality experience in relation to a measured arsenic trioxide exposure。Environ Health perspect,19,127-130。  new window
84.Enterlin, P. E.、Marsh, G. M.(1982)。Mortality among workers exposed to arsenic and other substances in a copper smelter。Am J Epidemiol,116,895-910。  new window
85.Goldman, A. L.(1973)。Lung cancer in Bowen's disease。Am Rev Resp Dis,108,1205-1207。  new window
86.Kasper, M. L.、Schoenfield, L.、Strom, R. L.、Theologides, A.(1984)。Hepatic angiosarcoma and bronchioloalveolar carcinoma induced by Fowler's solution。J Am Med Assoc,252,3407-3408。  new window
87.Jacobson, K. D.、Montaibano, D.(1985)。The reproductive effects assessment group's report on the mutagenicity of inorganic arsenic。Environ Mutagen,7,787-804。  new window
88.Lee, T. C.、Tanaka, N.、Lamb, P. W.、Gilmer, T. M.、Barrett, J. C.(1988)。Induction of gene amplification by arsenic。Science,241(4861),79-81。  new window
89.Deng, J. S.、How, S. W.(1977)。Comparison of the fine struo ture of basal cell carcinmas in ordinary paitents and patients with chronic arsenicalism。J Formosan Med Assoc,76,685-692。  new window
90.Currie, A. N.(1947)。The role of arsenic in carcinogenesis。Br Med Bull,2,402-405。  new window
91.Hill, G. C.(1964)。Arsenic induced carcinoma of the skin and lung。Pennsylvania Med J,67,35-38。  new window
92.Wang, B. J.、Lee, Y. Y.、Mak, C. P.、Kao, H. F.、Hsu, M. L.、Hsien, J. R.(1991)。Quantitative and morphological changes of Isngerhans cell in Bowen's disease from patient with chronic arsenicism。J Formosan Med Assoc,90(11),1093-1098。  new window
93.Yu, H. S.、Chen, G. S.、Sheu, H. M.、Kao, J. S.、Chang, K. L.、Yu, C. L.(1992)。Alteration of skin-associated lymphoid tissue in the carcinogenesis of arsenical skin can- car。Proc Natl Sci Counc, ROC, Part B: Life Sciences,16(1),17-22。  new window
94.Sheu, H. M.、Kao, J. S.、Yu, H. S.(1991)。Skin neoplasms solitary and multiple expression of keratin 16 in Bowen's disease。J Formosan Med Asso,90(12),1252。  new window
95.Chang, W. C.、Chen, S. H.、Wu, H. L.、Shi, G. Y.、Murota, S. I.、Morita, I.(1991)。Cytoprotective effect of reduced glutathione in arsenic induced endothelial cell injury。Toxicology,69,101-110。  new window
96.Gonsebatt, M. E.、Vega, L.、Herrera, L. A.、Montero, R.、Rojas, E.、Cebrian, M. E.、Ostroskg, W. P.(1992)。Inorganic arsenic effects on human lymphocyte stimulation and proliferation。Mut Res,283,91-95。  new window
97.Li, J. H.、Rossman, T. G.(1989)。Inhibition of DNA ligase activity by arsenite: a possible mechanism of its mutagenesis。Mol Toxicol,2,1-9。  new window
98.Nordenson, I.、Solmonsson, S.、Brun, E.、Beckman, G.(1979)。Chromosome aberrations in psoriatic patients treated with arsenic。Hum Genet,48,1-6。  new window
99.Rodl, S.、Fuchs, G.、Khoshsorur, G.、Iberer, F.、Tsche- liessnigg, K. H.(1990)。Lipoprotein-induced modulation of cyclosprotein-a-mediated immunosuppression。Eur J Clin Invest,20,248-252。  new window
100.Penn, I.(1988)。Tumors of the immunocompromised patient。Annu Rev Med,39,63-73。  new window
101.Yu, H. S.、Chang, K. L.、Wang, C. M.、Yu, C. L.(1992)。Alternations of mitogenic response of Dermatoll Dear cell by arsenic in arsenical skin cancer。J Dermotol,19(11),710-714。  new window
102.Geyer, L.(1898)。Uber die chronischen Hautrerande rungen beim Arsenicsmus und Betrachtungen Uber die Masemer Krankun-gen in Reichenstein in Selesien。Arch Dermatol,43,221-283。  new window
103.Bergoglio, R. M.(1964)。Mortality from cancer in regions of arsenical waters of the province of Cordoba。Pren Med Argent,51,994-998。  new window
104.Chavez, A.、Perez, H. C.、Tovar, E.、Garmilla, M.(1964)。Studies in a community with chronic endemic arsenic poisoning。Salud Publica Mex,6,435-442。  new window
105.Huang, Y. Z.、Qian, X. C.、Xiao, B. Y.、Wang, G. Q.、Ren, D. D.、Feng, Z. Y.、Wu, J. Y.、Xu, R. F.、Zhang, F. E.(1985)。Endemic chronic arsenicism in Xinjiang。Chin Med J Peking,98(3),219-222。  new window
106.Zalidvar, R.(1977)。Ecological Investigations on Arsenic Dietary Intake and Endemic Chronic Poisoning in Man: Dose-Response Curve。Zentralbl Bakteriol Parasitenkd Infektionskr Hyg Abt 1: Orig Reihe B,164(5/6),481-484。  new window
107.Biagini, R. E.(1974)。Present considerations on endemic chronic reginoal hydroarsenism。La Semana Medica,145,716-723。  new window
108.Wagner, S. L.、Maliner, J.、Morton, W. E.、Braman, R. S.(1979)。Skin cancer and arsenic intoxication from well water。Arch Dermatol,115,1205-1207。  new window
109.Chen, K. S.、Huang, C. C.、Chiliaw, C. C.、Chen, T. J.(1988)。Multiple primary cancers in blackfoot endemic area: Report of a case。J Formosan Med Assoc,87,1125-1128。  new window
110.Brown, K. G.、Boyle, K. E.、Chen, C. W.、Gibb, H. J.(1989)。A does-response analysis of skin cancer from inorganic arsenic in drinking water。Risk Analysis,9(4),519-528。  new window
111.Morton, W.、Starr, G.、Pohl, D.、Stoner, J.、Wagner, S.、Weswig, P.(1976)。Skin cancer and water arsenic in Lane County, Oregon。Cancer,37,2523-2532。  new window
112.Wong, O.、Whorton, M. D.、Foliart, D. E.、Lowengart, R.(1992)。An ecologic study of skin cancer and environmental arsenic exposure。Int Arch Occup Environ Health,64,235-241。  new window
113.Phillip, R.、Hughes, A. O.、Robertson, M. C.、Mitchell, T. F.(1983)。Malignant melanoma incidence and assoccition with arsenic。Bristol Med Chir J,98(368),165-169。  new window
114.Morris, J. M.、Schmid, M.、Newman, S.、Scheuer, P. J.、Sherlock, S.(1974)。Arsenic and noncirrhotic portal hypertension。Gastroenterology,64,86-94。  new window
115.Jackson, R.、Gainge, J. W.(1975)。Arsenic and cancer。Can Med Assoc J,113(5),396-401。  new window
116.Roat, J. W.、Wald, A.、Mendelow, H.、Pataki, K. l.(1982)。Hepatic angiosarcoma associated with short-term arsenic ingestion。Am J Med,73,933-936。  new window
117.Knoth, W.(1966)。Arsenbehandlung。Arch Klin Exp Derm,227,228-234。  new window
118.Cuzik, J.、Evans, S.、Gillman, M.、Price, E. D.(1982)。Medicinal arsenic and internal malignancies。Br J Cancer,45,904-911。  new window
119.Liebegott, L.(1952)。Relationships between chronic arsenical poisoning and malignant neoplasms。Zbl Arbeitsmed,2,15-16。  new window
120.Roth, F.(1957)。Concerning the delayed effects of the chronic arsenic of the moselle wine growers。Dtsch Med Wochenschr,82,211-217。  new window
121.Braun, W.(1958)。Carcinoma of the skin and the internal organs caused by arsenic: delayed occupational lesions due to arsenic。German Med Monthly,3,321-324。  new window
122.Luchtrath, H.(1972)。Liver cirrhosis due to chronic arsenic intoxication in vintners。Dtsch Med Wochenschr,97,21-22。  new window
123.Tsuda, T.、Nagira, T.、Yamamoto, M.、Kume, Y.(1990)。An Epidemiological Study on cancer in certified arsenic poisoning patients in Toroku。Ind Health,28,53-62。  new window
124.Chen, S. Y.、Yu, H. S.、Cheng, G. S.、Kuo, T. L.、Chen, C. J.(1993)。Early arsenic exposure and cancer a community based case-control study in an endemic area of blackfoot disease。Chinese J Natl Public Health,12(1),1-9。  new window
125.Hsueh, Y. M.、Cheng, G. S.、Wu, M. M.、Yu, H. S.、Kuo, T. L.、Chen, C. J.(1995)。Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status。Br J Cancer,71,109-114。  new window
126.Jelinek, C. F.、Corneliusen, R. E.(1977)。Levels of arsenic in the United States food supply。Environ Health Perspect,19,83-89。  new window
127.Blackwell, R. Q.(1961)。Estimated total arsenic ingested by residents in the endemic black foot area。J Formosan Med Assoc,60,1143。  new window
128.Marafante, E.、Vahter, M.(1984)。The effect of methyltransferase inhibition on the metabolism of [74As] arsenite in mics and rabbits。Chem Biol Interact,50,49-57。  new window
129.Buchet, J. P.、Lau, W. R.(1985)。Study of inorganic arsenic methylation by rat liver in vitro: Relevance for the interpretation of observation in man。Arch Toxicol,57,125-129。  new window
130.Marafante, E.(1986)。The effect of dietary and chemically induced methylation deficiency on the metabolism of arsenate in the rabbit。Acta Pharmacol Toxicol,59(Suppl 7),35-38。  new window
131.Vahter, M.、Marafante, E.(1987)。Effect of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit。Toxicol Lett,37,41-46。  new window
132.Yang, T. H.、Blackwell, R. Q.(1961)。Nutritional and environmental conditions in the endemic blackfoot area。Formosan Sci,15,101-129。  new window
133.Peto, R.、Doll, R.、Buckley, J. D.(1981)。Can dietary beta carotene materially reduce human cancer rates?。Nature,290,201-208。  new window
134.Shekella, R. B.、Lepper, M.、Liu, S.(1981)。Dietary vitamin A and risk of cancer in the western electric study。Lancet,2,1186-1190。  new window
135.Willet, W. C.、Polk, B. F.、Morris, J. S.(1983)。Prediag nostic serum selenium and risk of cancer。Lancet,2,130-134。  new window
136.Shamberger, R. J.、Tytko, S. A.、Willis, C. E.(1976)。Antioxidants and cancer: VI Selenium and age-adjusted of human cancer mortality。Arch Environ Health,31,231-235。  new window
137.Hu, G. G.(1989)。Investigation of protective effect of selenium on genetic materials among workers exposed to arsenic23(5),286-288。  new window
138.陳拱北、吳新英、吳登中(19621000)。Epidemiologic Studies on Blackfoot Disease in Taiwan。國立臺灣大學醫學院研究報告,8(1/2),115-129。  延伸查詢new window
139.Tseng, W. P.、Chu, H. M.、How, S. W.、Fong, J. M.、Lin, C. S.、Yeh, S.(1968)。Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan。J Natl Cancer Inst,40,453-463。  new window
140.Chen, C. J.、Chuang, Y. C.、Lin, T. M.、Wu, H. Y.(1985)。Malignant Neoplasms among Residents of a Blackfoot Disease-Endemic Area in Taiwan: High-Arsenic Artesian Well Water and Cancers。Cancer Research,45(11),5895-5899。  new window
141.陳建仁、王琪珍(1990)。Ecological Correlation between Arsenic Level in Well Water and Age-Adjusted Mortality from Malignant Neoplasms。Cancer Research,50,5470-5474。  new window
會議論文
1.Borgono, J. M.、Greiber, R.。Epidemiological study of arsenic in the city of Antofagasta。Trace Substances in Environmental Health V, proceedings of the 5th Annual Conference,Hemphill, D. C. ed. 。University of Missouri, Columbia。13-24。  new window
研究報告
1.Sanchez, de la Fuente E.。Chronic arsenicals in the rural area of the lake district, 1962-1964.。  new window
圖書
1.Muir, C. S.、Waterhouse, J.、Mack, T.、Powell, J.、Whelan, S. L.(1987)。Cancer Incidence in Five Continents。Lyon:IARC。  new window
2.Scotto, J.、Fears, T. R.、Fraumeni, J. F. Jr.(1983)。Incidence of nonmelanoma skin cancer in the United States。Bethesda, MD:NIH。  new window
3.Sullivan, R. J.(1969)。Preliminary air pollution survey of arsenic and its compounds: a literature review。Raleigh, NC:US Department of Health, Education and welfare:National Air Pollution Control Administration。  new window
4.Jacobosn, K. D.、Mushak, P.、Riscator, M.(1984)。Health Assessment Document for Inorganic Arsenic。Washington, DC:Environmental Protection Agency。  new window
5.Webb, J. L.(1966)。Enzyme and Metabolic Inhibitors。New York:Academic Press。  new window
6.Environmental Protection Agency、Risk assessment forum。Special report on ingested inorganic arsenic: Skin cancer, Nutritional essentiality。Washington DC:Environmental Protection Agency。  new window
7.World Health Organization(1981)。Environmental Health Criteria 18: Arsenic。Geneva:World Health Organization。  new window
8.Higgins, I.、Welch, K.、Burchfiel, C.(1982)。Mortality of Anaconda smelter workers in relation to arsenic and other exposures。Ann Arbor, Ml:Department of Epidemiology, University of Michigan。  new window
單篇論文
1.EPA(1984)。Health Effects Assessment for Arsenic(EPA/540/1-86/020)。,Washington, DC:Environmental Protection Agency, Office of Emergency and Remedial Response。  new window
2.EPA,Risk Assessment Forum(1987)。Special Report on Ingested Inorganic Arsenic: Skin cancer; Nutritional Essentiality(EPA/625/3-S7/013)。  new window
其他
1.International Agency for Research on Cancer(1987)。IARC graphs on the Evaluation of Carcinogenic Risks to Human,Lyon, France:World Health Organization。  new window
圖書論文
1.Scotto, J. P.、Fraumeni, J. F. Jr.(1982)。Skin (other than melanoma)。Cancer Epidemiology and Prevention。Philadelphia, PA:Saunders。  new window
2.Carter, D. M.(1992)。Basal cell carcinoma。Den Dermatology in General Medicine。New York, NY:McGraw-Hill。  new window
3.Yuspa, S. H.(1987)。Carcinogenesis: chemical。Dermatology in General Medicine。New York:McGraw-Hill。  new window
4.Scotto, J.、Fears, T. R.、Fraumeni, J. F. Jr.(1982)。Solar radiation。Cancer Epidemiology and Prevention。Philadelphia, PA:Saunders。  new window
5.Pathak, M. A.、Fitzpatrick, T. B.、Greiter, F.(1987)。Preventive treatment of sunburn, dermatoheliosis, and skin cancer with sun-proctective agents。Dermatology in General Medicine。New York, NY:McGraw-Hill。  new window
6.Schwartz, R. A.、Stoll, H. L.(1987)。Epithelial recancerous lesions。Dermatology in General Medicine。New Yourk:NY, McGraw-Hill。  new window
7.Sanderson, K. V.(1976)。Arsenic and skin cancer。Cancer of the skin。Philadelphia:WB Saunders。  new window
8.NAS。Arsenic。Prepared by committee on medical and biologica effects of environmental pollutants. Division of Medical Sciences。Washington, DC。  new window
9.Vahter, M. E.(1988)。Arsenic。Biological monitoring of toxic metal。New York:Plenum。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE